These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12958598)

  • 1. No association of germline alteration of MSR1 with prostate cancer risk.
    Wang L; McDonnell SK; Cunningham JM; Hebbring S; Jacobsen SJ; Cerhan JR; Slager SL; Blute ML; Schaid DJ; Thibodeau SN
    Nat Genet; 2003 Oct; 35(2):128-9. PubMed ID: 12958598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germ-line alterations in MSR1 gene and prostate cancer risk.
    Seppälä EH; Ikonen T; Autio V; Rökman A; Mononen N; Matikainen MP; Tammela TL; Schleutker J
    Clin Cancer Res; 2003 Nov; 9(14):5252-6. PubMed ID: 14614006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the macrophage scavenger receptor 1 gene in Swedish hereditary and sporadic prostate cancer.
    Lindmark F; Jonsson BA; Bergh A; Stattin P; Zheng SL; Meyers DA; Xu J; Grönberg H
    Prostate; 2004 May; 59(2):132-40. PubMed ID: 15042613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germline mutations of the MSR1 gene in prostate cancer families from Germany.
    Maier C; Vesovic Z; Bachmann N; Herkommer K; Braun AK; Surowy HM; Assum G; Paiss T; Vogel W
    Hum Mutat; 2006 Jan; 27(1):98-102. PubMed ID: 16287155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage scavenger receptor 1 999C>T (R293X) mutation and risk of prostate cancer.
    Hope Q; Bullock S; Evans C; Meitz J; Hamel N; Edwards SM; Severi G; Dearnaley D; Jhavar S; Southgate C; Falconer A; Dowe A; Muir K; Houlston RS; Engert JC; Roquis D; Sinnett D; Simard J; Heimdal K; Møller P; Maehle L; Badzioch M; Eeles RA; Easton DF; English DR; Southey MC; Hopper JL; Foulkes WD; Giles GG;
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):397-402. PubMed ID: 15734964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational analysis of susceptibility genes RNASEL/HPC1, ELAC2/HPC2, and MSR1 in sporadic prostate cancer.
    Nupponen NN; Wallén MJ; Ponciano D; Robbins CM; Tammela TL; Vessella RL; Carpten JD; Visakorpi T
    Genes Chromosomes Cancer; 2004 Feb; 39(2):119-25. PubMed ID: 14695991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the Nijmegen breakage syndrome 1 gene in familial and sporadic prostate cancer.
    Hebbring SJ; Fredriksson H; White KA; Maier C; Ewing C; McDonnell SK; Jacobsen SJ; Cerhan J; Schaid DJ; Ikonen T; Autio V; Tammela TL; Herkommer K; Paiss T; Vogel W; Gielzak M; Sauvageot J; Schleutker J; Cooney KA; Isaacs W; Thibodeau SN
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):935-8. PubMed ID: 16702373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germline ATBF1 mutations and prostate cancer risk.
    Xu J; Sauvageot J; Ewing CM; Sun J; Liu W; Isaacs SD; Wiley KE; Diaz L; Zheng SL; Walsh PC; Isaacs WB
    Prostate; 2006 Jul; 66(10):1082-5. PubMed ID: 16637072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of HPC2/ELAC2 in hereditary prostate cancer.
    Wang L; McDonnell SK; Elkins DA; Slager SL; Christensen E; Marks AF; Cunningham JM; Peterson BJ; Jacobsen SJ; Cerhan JR; Blute ML; Schaid DJ; Thibodeau SN
    Cancer Res; 2001 Sep; 61(17):6494-9. PubMed ID: 11522646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germ-line mutations of the macrophage scavenger receptor 1 gene: association with prostate cancer risk in African-American men.
    Miller DC; Zheng SL; Dunn RL; Sarma AV; Montie JE; Lange EM; Meyers DA; Xu J; Cooney KA
    Cancer Res; 2003 Jul; 63(13):3486-9. PubMed ID: 12839931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variants in the prostate-specific antigen (PSA) gene and prostate cancer risk, survival, and circulating PSA.
    Severi G; Hayes VM; Neufing P; Padilla EJ; Tilley WD; Eggleton SA; Morris HA; English DR; Southey MC; Hopper JL; Sutherland RL; Boyle P; Giles GG
    Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1142-7. PubMed ID: 16775173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of sequence variants in interleukin-1 receptor-associated kinase4 and the toll-like receptor 6-1-10 gene cluster increase prostate cancer risk.
    Sun J; Wiklund F; Hsu FC; Bälter K; Zheng SL; Johansson JE; Chang B; Liu W; Li T; Turner AR; Li L; Li G; Adami HO; Isaacs WB; Xu J; Grönberg H
    Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):480-5. PubMed ID: 16537705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk.
    Xu J; Zheng SL; Komiya A; Mychaleckyj JC; Isaacs SD; Hu JJ; Sterling D; Lange EM; Hawkins GA; Turner A; Ewing CM; Faith DA; Johnson JR; Suzuki H; Bujnovszky P; Wiley KE; DeMarzo AM; Bova GS; Chang B; Hall MC; McCullough DL; Partin AW; Kassabian VS; Carpten JD; Bailey-Wilson JE; Trent JM; Ohar J; Bleecker ER; Walsh PC; Isaacs WB; Meyers DA
    Nat Genet; 2002 Oct; 32(2):321-5. PubMed ID: 12244320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variability in inflammation pathways and prostate cancer risk.
    Sun J; Turner A; Xu J; Grönberg H; Isaacs W
    Urol Oncol; 2007; 25(3):250-9. PubMed ID: 17483024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germline mutation analysis of the androgen receptor gene in Finnish patients with prostate cancer.
    Koivisto PA; Hyytinen ER; Matikainen M; Tammela TL; Ikonen T; Schleutker J
    J Urol; 2004 Jan; 171(1):431-3. PubMed ID: 14665948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Germ-line mutation of NKX3.1 cosegregates with hereditary prostate cancer and alters the homeodomain structure and function.
    Zheng SL; Ju JH; Chang BL; Ortner E; Sun J; Isaacs SD; Sun J; Wiley KE; Liu W; Zemedkun M; Walsh PC; Ferretti J; Gruschus J; Isaacs WB; Gelmann EP; Xu J
    Cancer Res; 2006 Jan; 66(1):69-77. PubMed ID: 16397218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA variation in MSR1, RNASEL and E-cadherin genes and prostate cancer in Poland.
    Cybulski C; Wokołorczyk D; Jakubowska A; Gliniewicz B; Sikorski A; Huzarski T; Debniak T; Narod SA; Lubiński J
    Urol Int; 2007; 79(1):44-9. PubMed ID: 17627168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germline mutations in fumarate hydratase (FH) do not predispose to prostate cancer.
    Bevan S; Edwards SM; Ardern Jones A; Dowe A; Southgate C; Dearnaley D; Easton DF; Houlston RS; Eeles RA;
    Prostate Cancer Prostatic Dis; 2003; 6(1):12-4. PubMed ID: 12664059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk.
    Xu J; Zheng SL; Komiya A; Mychaleckyj JC; Isaacs SD; Chang B; Turner AR; Ewing CM; Wiley KE; Hawkins GA; Bleecker ER; Walsh PC; Meyers DA; Isaacs WB
    Am J Hum Genet; 2003 Jan; 72(1):208-12. PubMed ID: 12471593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kruppel-like factor 6 germ-line mutations are infrequent in Finnish hereditary prostate cancer.
    Koivisto PA; Hyytinen ER; Matikainen M; Tammela TL; Ikonen T; Schleutker J
    J Urol; 2004 Aug; 172(2):506-7. PubMed ID: 15247715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.